key articles
Cancer incidence before and after kidney transplantation
by Vajdic CM,McDonald CM, McCredie MRE, van Leeuwen MT, Stewart JH, Law M,Chapman JR, Webster AC, Kaldor JM,Grulich AE
It is well known that immunosuppression following renal transplantation is associated with a marked increase...
Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation
Hyperhomocysteinemia and high IL-18 expression in renal allograft recipients may be independent markers of early atherosclerosis development
Transplantation Proceedings Vol. 38
Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine
Steroid withdrawal in low risk kidney transplant recipients is safe and ameliorates many of the unwanted sides effects of steroid use
Clinical Transplantation Vol. 20
FTY720 versus MMF with cyclosporine in de novo renal transplantation: A 1-year, randomized controlled trial in Europe and Australasia
FTY720 is a novel immunomodulator investigated in de novo renal transplantation and other therapeutic areas including multiple sclerosis
American Journal of Transplantation Vol. 6
Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients
FTY720, a sphingosine-1-phosphate receptor agonist, is the archeotype of a new class of immune modulators, which redirects lymphocytes from the peripheral blood into secondary lymphatic tissue
International Immunopharmacology Vol. 7
Living related kidney transplantation without calcineurin inhibitors: Initial experience in a Mexican center
We performed a prospective randomized trial comparing sirolimus/ mycophenolate mofetil (MMF)/prednisone to cyclosporine/MMF/prednisone and selected induction therapy with basiliximab
Transplantation Vol. 82
Efficacy of High-Dose Trimethoprim-Sulfamethoxazol Prophylaxis on Early Urinary Tract Infection After Renal Transplantation
Urinary tract infection (UTI), a major cause of morbidity in renal transplant recipients, has also been found to increase mortality
Transplantation Proceedings Vol. 38
Long-Term Results of Monoclonal Anti-Il2-Receptor Antibody Versus Polyclonal Antilymphocyte Antibodies as Induction Therapy in Renal Transplantation
We compared the influence of induction therapy on 5-year patient and graft survival as well as on renal function in 100 kidney graft recipients
Transplantation Proceedings Vol. 38
